Barely Significant
← all excerpts

Significant survival benefit of adjuvant chemotherapy after concurrent chemoradiotherapy in locally advanced high-risk nasopharyngeal carcinoma.

Sci Rep · 2017 · PMC5288719 · PMID 28150694

Europe PMCDOI
1
hedged sentence
0.0520
closest p · 1.0× alpha
0.0520
boldest claim

The sentences

borderline significantP = 0.052so close (0.05 < p ≤ 0.1)
After a mean follow-up time of 42.1 months, a borderline significant benefit was found for patients with N2-N3 stage disease (HR, 0.35; 95% CI, 0.11–1.06; P = 0.052).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.